Cincinnati Children’s spinout, Airway Therapeutics, receives key FDA approval


A Greater Cincinnati biopharma startup that’s developing new interventions for acute and chronic lung diseases – including for very preterm infants and Covid-19 patients – received a key FDA approval last week.

Click here to read the complete story.

Story excerpt provided by Cincinnati Business Courier.

Written by Liz Engel.

Originally published March 31, 2021.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: